8VC

8VC is a technology and bio-sciences investment firm which invests in the world’s most ambitious and innovative companies.

United Statesseed
Firm site

Firm

Firm

8VC is a technology and bio-sciences investment firm which invests in the world’s most ambitious and innovative companies. Posts News Oct 27, 2026 The Two-Antibody Problem: Announcing the BigHat-Anthropic Partnership Today, Anthropic and BigHat Biosciences announced a historic collaboration: a single Anthropic researcher, armed with Claude, operated BigHat’s automated lab to optimize two antibodies. This marks one of the first instances of a frontier AI lab and next-gen bio lab teaming up, and a potential watershed for drug discovery. 8VC is a technology investment firm that builds and invests in the world’s most ambitious companies. Announcing our Investment in Fragment October 28, 2026 We partner with leading entrepreneurs and innovators to build technology platforms that create lasting economic and societal value. [8VC In Brief] 8VC companies are transforming industries and pioneering new ones Life Sciences. Healthcare. Manufacturing. Enterprise. Logistics. Defense. News Posts October 27, 2026 The Two-Antibody Problem: Announcing the BigHat-Anthropic Partnership Today, Anthropic and BigHat Biosciences announced a historic collaboration: a single Anthropic researcher, armed with Claude, operated BigHat’s automated lab to optimize two antibodies. News Posts October 20, 2026 Orchestra Bio is Joining OpenAI Today, Orchestra announced they wi

Geography

Geography

United States

Stage

Stage

seed

Themes

Themes

AI · enterprise

Portfolio

Portfolio

Bedrock Robotics, Ramp, Casetext, Saronic, Hopscotch, Vercel, Anduril, Epirus, Yugabyte, Resilience, Orca Bio, City Block

About

About

Posts News Oct 27, 2026 The Two-Antibody Problem: Announcing the BigHat-Anthropic Partnership Today, Anthropic and BigHat Biosciences announced a historic collaboration: a single Anthropic researcher, armed with Claude, operated BigHat’s automated lab to optimize two antibodies. This marks one of the first instances of a frontier AI lab and next-gen bio lab teaming up, and a potential watershed for drug discovery. We are investors who never stopped being engineers, operators, policymakers, philosophers, and entrepreneurs. We are equally fervent realists and optimists, with an irreverence for convention and a reverence for wisdom. 01 What is possible now that wasn’t five years ago? 02 How can these breakthroughs create the most economic and societal value? There are myriad ways we can contribute to a better world, from saving lives to improving them. We support company missions as diverse as safer bone marrow transplants, zero-emission aircraft, enforcement of privacy laws, and rapid tunneling for less congested cities. This is ingrained in our motto These are a few of the values that inform where we i